These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 701847)

  • 21. Staphylococcal scalded skin syndrome: detection of antibody to epidermolytic toxin by a primary binding assay.
    Baker DH; Wuepper KD; Rasmussen JE
    Clin Exp Dermatol; 1978 Mar; 3(1):17-24. PubMed ID: 348359
    [No Abstract]   [Full Text] [Related]  

  • 22. Staphylococcus pseudintermedius exfoliative toxin EXI selectively digests canine desmoglein 1 and causes subcorneal clefts in canine epidermis.
    Iyori K; Futagawa-Saito K; Hisatsune J; Yamamoto M; Sekiguchi M; Ide K; Son WG; Olivry T; Sugai M; Fukuyasu T; Iwasaki T; Nishifuji K
    Vet Dermatol; 2011 Aug; 22(4):319-26. PubMed ID: 21410798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Qualitative and quantitative methods for detecting staphylococcal epidermolytic toxin.
    Arbuthnott JP; Billcliffe B
    J Med Microbiol; 1976 May; 9(2):191-201. PubMed ID: 819654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible binding of epidermolytic toxin to a subcellular fraction of the epidermis.
    Nishioka K; Katayama I; Sano S
    J Dermatol; 1981 Feb; 8(1):7-12. PubMed ID: 7014685
    [No Abstract]   [Full Text] [Related]  

  • 25. The epidermolytic toxins are serine proteases.
    Dancer SJ; Garratt R; Saldanha J; Jhoti H; Evans R
    FEBS Lett; 1990 Jul; 268(1):129-32. PubMed ID: 2384148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of blister formation by staphylococcal toxins.
    Hanakawa Y; Stanley JR
    J Biochem; 2004 Dec; 136(6):747-50. PubMed ID: 15671483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bullous impetigo caused by group A streptococci. A case report.
    Helsing P; Gaustad P
    Acta Derm Venereol; 1992; 72(1):50-1. PubMed ID: 1350146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A circular-dichroism study of epidermolytic toxins A and B from Staphylococcus aureus.
    Bailey CJ; Martin SR; Bayley PM
    Biochem J; 1982 Jun; 203(3):775-8. PubMed ID: 7115314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigen.
    Fleischer B; Bailey CJ
    Med Microbiol Immunol; 1992; 180(6):273-8. PubMed ID: 1549069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies of exfoliatin producing Staphylococcus aureus isolated from various diseases (author's transl)].
    Futaki S; Hirayama K; Ichizawa Y; Hosoya R; Sarai Y
    Nihon Hifuka Gakkai Zasshi; 1977 Sep; 87(10):609-16. PubMed ID: 303712
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical manifestations of staphylococcal scalded-skin syndrome depend on serotypes of exfoliative toxins.
    Yamasaki O; Yamaguchi T; Sugai M; Chapuis-Cellier C; Arnaud F; Vandenesch F; Etienne J; Lina G
    J Clin Microbiol; 2005 Apr; 43(4):1890-3. PubMed ID: 15815014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermolytic toxin binds to components in the epidermis of a resistant species.
    Smith TP; John DA; Bailey CJ
    Eur J Cell Biol; 1989 Aug; 49(2):341-9. PubMed ID: 2476313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel Staphylococcus pseudintermedius exfoliative toxin gene and its prevalence in isolates from canines with pyoderma and healthy dogs.
    Iyori K; Hisatsune J; Kawakami T; Shibata S; Murayama N; Ide K; Nagata M; Fukata T; Iwasaki T; Oshima K; Hattori M; Sugai M; Nishifuji K
    FEMS Microbiol Lett; 2010 Nov; 312(2):169-75. PubMed ID: 20875053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidermolytic (exfoliative) toxins of Staphylococcus aureus.
    Bailey CJ; Lockhart BP; Redpath MB; Smith TP
    Med Microbiol Immunol; 1995 Aug; 184(2):53-61. PubMed ID: 7500911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staphylococcus aureus penetrate the interkeratinocyte spaces created by skin-infiltrating neutrophils in a mouse model of impetigo.
    Imanishi I; Hattori S; Hisatsune J; Ide K; Sugai M; Nishifuji K
    Vet Dermatol; 2017 Feb; 28(1):126-e27. PubMed ID: 27862501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staphylococcal scalded skin syndrome. II. Serum level of anti exfoliatin and anti alpha-toxin in patients with staphylococcal scalded skin syndrome or bullous impetigo.
    Nishioka K; Nakano T; Hirao N; Teranishi H; Asada Y
    J Dermatol; 1977 Apr; 4(2):65-8. PubMed ID: 15461328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The reactive serine residue of epidermolytic toxin A.
    Bailey CJ; Smith TP
    Biochem J; 1990 Jul; 269(2):535-7. PubMed ID: 2117445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitive and specific detection of staphylococcal epidermolysins A and B in broth cultures by flow cytometry-assisted multiplex immunoassay.
    Joubert O; Keller D; Pinck A; Monteil H; Prévost G
    J Clin Microbiol; 2005 Mar; 43(3):1076-80. PubMed ID: 15750064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of two serotypes of epidermolytic toxin from Staphylococcus aureus.
    Bailey CJ; de Azavedo J; Arbuthnott JP
    Biochim Biophys Acta; 1980 Jul; 624(1):111-20. PubMed ID: 6773585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kampo medicines suppress the production of exfoliative toxins causing impetigo in Staphylococcus aureus.
    Katayama I; Nakaminami H; Yamada T; Ikoshi H; Noguchi N
    J Dermatol; 2020 Jul; 47(7):714-719. PubMed ID: 32415796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.